You need to enable JavaScript to run this web app.
mTOR Signaling in Metabolism and Cancer
The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, is a central regulator for human physiological activity. Deregulated mTOR signaling is implicated in a variety of disorders, such as cancer, obesity, diabetes, and neurodegenerative diseases. The papers published in this Special Issue summarize the current understanding of the mTOR pathway and its role in the regulation of tissue regeneration, regulatory T cell differentiation and function, and different types of cancer including hematologic malignancies, skin, prostate, breast, and head and neck cancer. The findings highlight that targeting mTOR pathway is a promising strategy to fight against certain human diseases.

× Full-Screen Image < >
Der er i øjeblikket ingen priser på dette produkt.
Se evt historiske priser under Prisudvikling.
-- Beklager, Historiske data er i øjeblikket ikke tilgængelige --
Reload:N, Cached:Y (1194 sec left)
Page generated in 1.4501 msec.
online database: main